218 related articles for article (PubMed ID: 26012467)
1. [A new method in biotechnology].
Hofmann-Aßmus M
MMW Fortschr Med; 2015 Apr; 157(7):75. PubMed ID: 26012467
[No Abstract] [Full Text] [Related]
2. [The affair "Crispr-Cas9" or genetically enhanced humanity].
Nau JY
Rev Med Suisse; 2014 Jun; 10(436):1428-9. PubMed ID: 25055481
[No Abstract] [Full Text] [Related]
3. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
Grenier F; Lucier JF; Rodrigue S
Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
[TBL] [Abstract][Full Text] [Related]
4. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems.
Giovannangeli C; Concordet JP
Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487
[No Abstract] [Full Text] [Related]
5. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
Duroux-Richard I; Giovannangeli C; Apparailly F
Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565
[No Abstract] [Full Text] [Related]
6. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
[TBL] [Abstract][Full Text] [Related]
7. [CRISPR-Cas system as molecular scissors for gene therapy].
Heinz GA; Mashreghi MF
Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
[TBL] [Abstract][Full Text] [Related]
8. Plant genome engineering in full bloom.
Lozano-Juste J; Cutler SR
Trends Plant Sci; 2014 May; 19(5):284-7. PubMed ID: 24674878
[TBL] [Abstract][Full Text] [Related]
9. Optical Control of CRISPR/Cas9 Gene Editing.
Hemphill J; Borchardt EK; Brown K; Asokan A; Deiters A
J Am Chem Soc; 2015 May; 137(17):5642-5. PubMed ID: 25905628
[TBL] [Abstract][Full Text] [Related]
10. [Not Available].
Nau JY
Rev Med Suisse; 2016 Apr; 12(514):766-7. PubMed ID: 27263157
[No Abstract] [Full Text] [Related]
11. [The revolution of the CRISPR is underway].
Gilgenkrantz H
Med Sci (Paris); 2014 Dec; 30(12):1066-9. PubMed ID: 25537031
[No Abstract] [Full Text] [Related]
12. Targeted mutagenesis in Zea mays using TALENs and the CRISPR/Cas system.
Liang Z; Zhang K; Chen K; Gao C
J Genet Genomics; 2014 Feb; 41(2):63-8. PubMed ID: 24576457
[TBL] [Abstract][Full Text] [Related]
13. CRISPR adaptation in Escherichia coli subtypeI-E system.
Kiro R; Goren MG; Yosef I; Qimron U
Biochem Soc Trans; 2013 Dec; 41(6):1412-5. PubMed ID: 24256229
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 for genome editing: progress, implications and challenges.
Zhang F; Wen Y; Guo X
Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
[TBL] [Abstract][Full Text] [Related]
15. Cas9 immunity creates challenges for CRISPR gene editing therapies.
Crudele JM; Chamberlain JS
Nat Commun; 2018 Aug; 9(1):3497. PubMed ID: 30158648
[TBL] [Abstract][Full Text] [Related]
16. Computational Detection of CRISPR/crRNA Targets.
Biswas A; Fineran PC; Brown CM
Methods Mol Biol; 2015; 1311():77-89. PubMed ID: 25981467
[TBL] [Abstract][Full Text] [Related]
17. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
Mashimo T
Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
[TBL] [Abstract][Full Text] [Related]
18. CRISPR germline editing reverberates through biotech industry.
Sheridan C
Nat Biotechnol; 2015 May; 33(5):431-2. PubMed ID: 25965729
[No Abstract] [Full Text] [Related]
19. [Enhancing our single molecule experience using Crispr].
Gaudin R
Med Sci (Paris); 2015 Nov; 31(11):959-61. PubMed ID: 26576600
[No Abstract] [Full Text] [Related]
20. Harnessing CRISPR-Cas systems for bacterial genome editing.
Selle K; Barrangou R
Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]